Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will receive a milestone payment following the pricing approval and launch of FRUZAQLA® (fruquintinib) 1mg/5mg capsules in Japan ...

Alumis’ lead drug candidate, ESK-001, is a Tyrosine Kinase 2 (TYK2) inhibitor currently in Phase 3 trials for moderate ... fruquintinib), a selective oral inhibitor of vascular endothelial growth ...

Every STALKER 2 guide you could need for the game’s early hours is here, as we’ve covered everything from the best guns and how to repair them to survival tips and which choices to make for ...

So who's in the Gladiator sequel and when can we expect it? Here is everything that we know about Gladiator 2. Here is the official plot of Gladiator 2, from a script written by David Scarpa: "From ...

However, as is shown in Table 2, at least 29 approved targeted drugs are now under investigation in Phase II or higher studies investigating the use of RT in combination with targeted drugs in ...

Background Tyrosine kinase 2 (Tyk2) is a member of the JAK family that phosphorylates STAT proteins downstream of the IL-12, IL-23 and the Type I interferon receptor. Tyk2 genetic variants have been ...

using both modalities sequentially (Figures 1 and 2). Strictly speaking, radiosensitizers shouldn't have inherent cytotoxic activity. The hypoxic cell sensitizers (e.g. misonidazole), and ...